| Name | Title | Contact Details |
|---|
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.
Dental Pay Plus is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
VisualMED Clinical Solutions Corp. is a Outremont, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Gambro Renal Products is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Gambro Renal Products is based in Lakewood, CO. You can find more information on Gambro Renal Products at www.gambro.com
PayLess Drug Stores is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Portland, OR. To find more information about PayLess Drug Stores, please visit www.paylessdrug.com